The mechanism of m6A modification in cardiovascular diseases: A systematic review. [PDF]
Liu H, Song T, Huang Y.
europepmc +1 more source
Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA. [PDF]
Wu X +8 more
europepmc +1 more source
Correction: Epigenetics in neonatal necrotizing enterocolitis: current understanding and the potential involvement of m6A modification. [PDF]
Chen Y, Chen Y.
europepmc +1 more source
m6A modification of non‑coding RNA: Mechanisms, functions and potential values in human diseases (Review). [PDF]
Yi Q +6 more
europepmc +1 more source
CAP1-Mediated m6A modification of RRM2 suppresses tumor-associated M2 macrophage polarization and colorectal cancer growth. [PDF]
Feng T +12 more
europepmc +1 more source
METTL3-mediated m6A modification of CXCR4 drives M2 macrophage polarization and suppresses anti-tumor immunity in esophageal cancer. [PDF]
Sun Y, Huang S.
europepmc +1 more source
Hsa_circ_0058495-mediated IGF2BP2 ubiquitination and m6A modification of MEKK1 promote the progression of PDAC. [PDF]
Lv S +10 more
europepmc +1 more source
METTL14-mediated m6A modification of DUSP6 mRNA participating in postoperative cognitive dysfunction due to sevoflurane anesthesia. [PDF]
Deng S, Mu G, Li J, Yu X, Li Q, Lu B.
europepmc +1 more source
The Dynamic Interactions of m6A Modification and R-Loops: Implications for Genome Stability. [PDF]
Kim N, Sun H.
europepmc +1 more source

